1990
DOI: 10.1016/0031-9384(90)90265-6
|View full text |Cite
|
Sign up to set email alerts
|

Salivary testosterone measurements: Reliability across hours, days, and weeks

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
178
3
3

Year Published

1996
1996
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 354 publications
(198 citation statements)
references
References 18 publications
14
178
3
3
Order By: Relevance
“…Alternatively, it could be a low-cost functionless byproduct of processes that function primarily to increase intrasexual competitiveness in response to changes in testosterone that occur over longer timespans, such as over pubertal development. Since some (but not all) studies have reported small increases in testosterone around ovulation (Caruso et al, 2014;Dabbs, 1990;Dabbs & de La Rue, 1991), we do not discount the possibility that increased intrasexual competitiveness when testosterone is high may occur because of direct or indirect benefits Hahn 14 associated with increased intrasexual competitiveness around ovulation (see Fisher, 2004).…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Alternatively, it could be a low-cost functionless byproduct of processes that function primarily to increase intrasexual competitiveness in response to changes in testosterone that occur over longer timespans, such as over pubertal development. Since some (but not all) studies have reported small increases in testosterone around ovulation (Caruso et al, 2014;Dabbs, 1990;Dabbs & de La Rue, 1991), we do not discount the possibility that increased intrasexual competitiveness when testosterone is high may occur because of direct or indirect benefits Hahn 14 associated with increased intrasexual competitiveness around ovulation (see Fisher, 2004).…”
Section: Discussionmentioning
confidence: 93%
“…Moreover, intrasexual competitiveness did not differ between these late-follicular or mid-luteal phases. Since hormonal contraceptive use lowers testosterone levels in women (Zimmerman et al, 2014) and evidence that testosterone levels change between the late-follicular and mid-luteal phases is mixed (Dabbs, 1990;Dabbs & de La Rue, 1991; see also Caruso et al, 2014), Cobey et al (2013) speculated that the observed changes in women's intrasexual competitiveness may be a consequence of changes in their testosterone levels. Indeed, this explanation would be consistent with findings showing that women's testosterone levels increased after they imagined their partner flirting with an attractive woman (Ritchie & van Anders, 2014) or were exposed to olfactory cues associated with ovulation in other women (Maner & McNulty, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Likewise, further studies could consider the influence of cycle phase in regularly cycling women, as there is some evidence to suggest that testosterone increases near to ovulation (e.g. Alexander, Sherwin, Bancroft, and Davidson 1990;Bloch, Schmidt, Su, Tobin, and Rubinow 1998;Dabbs 1990;Morris, Udry, KhanDawood, and Dawood 1987;Schultheiss, Dargel, and Rohde 2003;Welling et al 2007, but see Dabbs 1990;Liening, Stanton, Saini, and Schultheiss 2010;Schultheiss et al 2003), although this effect is unlikely to be large since daily fluctuations (due to circadian rhythm) and seasonal fluctuations in testosterone are often greater than cyclical changes.…”
Section: Discussionmentioning
confidence: 99%
“…This window was chosen to help control for diurnal rhythms in testosterone levels (e.g. Dabbs 1990). Upon reporting to the lab, participants provided informed consent and were then instructed to rinse their mouth with water.…”
Section: Methodsmentioning
confidence: 99%
“…Subjects were included whose blood samples were taken between 07:00 and 09:00 in order to minimize the in¯uence of diurnal rhythm of leptin 20 and androgen levels. 21 Subjects who were pregnant, had diabetes or subclinical hypothyroidism, or had a history of prior myocardial infarction or stroke, or were using estrogen replacement therapy, oral contraceptives or antihypertensive agents were excluded. Furthermore, women with irregular menstruations were excluded.…”
Section: Study Populationmentioning
confidence: 99%